RNA isolation reagent market set for double-digit growth through 2030

The global RNA isolation and enrichment reagent market is forecast to rise from $0.94 billion in 2025 to $1.04 billion in 2026, then reach $1.57 billion by 2030. Growth is being driven by molecular diagnostics, genomics research, high-throughput automation and the expanding use of AI in RNA analysis.

Why it matters: - RNA isolation and enrichment reagents sit at the front end of genomics, diagnostics and transcriptomics workflows. - Faster growth in these tools supports more accurate gene expression studies, sequencing and molecular testing across research and clinical settings. - The market’s expansion points to continued investment in life sciences infrastructure, automation and data-driven analysis.

What happened: - The Business Research Company projected the global RNA isolation and enrichment reagent market will grow from $0.94 billion in 2025 to $1.04 billion in 2026. - The report put the market on track to reach $1.57 billion by 2030. - The forecast implies 11.2% growth in 2026 and 10.7% annual growth through 2030. - The report was released in London on Sept. 22, 2026. - The company published the forecast in its Ribonucleic Acid (RNA) Isolation and Enrichment Reagent Global Market Report 2026 – Market Size, Trends, and Forecast 2026-2035. - The report includes a free sample and the full report.

The details: - RNA isolation and enrichment reagents are specialized chemicals and kits used to extract, purify and concentrate RNA from cells, tissues and blood. - These reagents remove DNA, proteins and other debris to preserve RNA integrity. - The market is benefiting from the shift to automated high-throughput RNA isolation systems. - Demand is also rising for transcriptomics-based drug discovery. - AI use in RNA data analysis is adding another growth driver. - Molecular diagnostics for infectious diseases is a major demand source. - Widespread adoption of next-generation sequencing is increasing the need for efficient RNA extraction methods. - Funding for academic and clinical genomics research is supporting innovation and lab infrastructure. - Biobanking and sample preservation facilities are encouraging early adoption of manual RNA extraction methods. - Precision medicine, rare disease research, laboratory robotics and digital ecosystems are expected to accelerate adoption further. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region over the forecast period. - The company said the 2026 report series adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspot infographics, key technology analysis and updated graphics.

Between the lines: - The forecast suggests RNA extraction remains a foundational bottleneck in the genomics stack, even as downstream analysis gets faster and more automated. - The strongest demand signals come from applications that need clean, high-quality RNA at scale, especially diagnostics, sequencing and drug discovery. - Regional growth appears to be shifting toward Asia-Pacific, while North America remains the largest installed market because of deeper research infrastructure. - The addition of analytics tools in the report reflects a broader market focus on decision support, not just raw size estimates.

What's next: - Growth should continue as labs adopt more automated systems and increase sequencing throughput. - Further demand is likely as precision medicine and rare disease research expand. - The market will also be shaped by robotics, digital lab workflows and AI-enabled RNA analysis. - North America and Asia-Pacific are likely to remain the key regions to watch.

The bottom line: - RNA isolation and enrichment reagents are moving from a niche lab input to a high-growth enabling market for modern genomics and diagnostics.